| 000 | 00773 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250513053937.0 | ||
| 264 | 0 | _c19950112 | |
| 008 | 199501s 0 0 spa d | ||
| 022 | _a0001-6896 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCermignani, E C | |
| 245 | 0 | 0 |
_a[Drugs epidemiology]. _h[electronic resource] |
| 260 |
_bActa psiquiatrica y psicologica de America latina _cJun 1994 |
||
| 300 |
_a106-14 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 650 | 0 | 4 | _aTechnology, Pharmaceutical |
| 773 | 0 |
_tActa psiquiatrica y psicologica de America latina _gvol. 40 _gno. 2 _gp. 106-14 |
|
| 999 |
_c7991958 _d7991958 |
||